Castle Biosciences (CSTL) News Today $19.50 -0.16 (-0.81%) Closing price 04:00 PM EasternExtended Trading$19.48 -0.02 (-0.10%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CSTL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025July 14 at 7:00 AM | globenewswire.comPrincipal Financial Group Inc. Purchases 32,208 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)July 9, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)July 7, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Palisade Capital Management LPJuly 3, 2025 | marketbeat.comCastle Biosciences, Inc. (CSTL) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comCastle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of "Buy" from AnalystsJune 21, 2025 | marketbeat.comCastle Biosciences, Inc.: Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 19, 2025 | finanznachrichten.deCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 19, 2025 | globenewswire.comCastle Biosciences partners with SciBase for diagnostic testsJune 17, 2025 | msn.comCastle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic DiseasesJune 16, 2025 | globenewswire.comCastle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc.June 15, 2025 | marketbeat.comCastle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International ConventionJune 11, 2025 | globenewswire.comSquarepoint Ops LLC Lowers Position in Castle Biosciences, Inc. (NASDAQ:CSTL)June 5, 2025 | marketbeat.comCastle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®June 4, 2025 | finance.yahoo.comShort Interest in Castle Biosciences, Inc. (NASDAQ:CSTL) Drops By 17.2%June 4, 2025 | marketbeat.comCastle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®June 4, 2025 | globenewswire.comMackenzie Financial Corp Takes $560,000 Position in Castle Biosciences, Inc. (NASDAQ:CSTL)June 3, 2025 | marketbeat.comWellington Management Group LLP Invests $19.24 Million in Castle Biosciences, Inc. (NASDAQ:CSTL)June 1, 2025 | marketbeat.comCastle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025May 30, 2025 | msn.comNew Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival OutcomesMay 29, 2025 | globenewswire.comNuveen Asset Management LLC Has $12.41 Million Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 28, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of "Buy" by BrokeragesMay 28, 2025 | marketbeat.comBank of America Corp DE Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 26, 2025 | marketbeat.comCastle Biosciences amends charter, stockholders voteMay 25, 2025 | investing.comMillennium Management LLC Has $14.63 Million Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 25, 2025 | marketbeat.com90,563 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Purchased by D. E. Shaw & Co. Inc.May 23, 2025 | marketbeat.comAmeriprise Financial Inc. Has $8.42 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 23, 2025 | marketbeat.comSoleus Capital Management L.P. Has $6.74 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 21, 2025 | marketbeat.comCastle Biosciences to Present at the 2025 Jefferies Global Healthcare ConferenceMay 21, 2025 | globenewswire.comJane Street Group LLC Reduces Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 21, 2025 | marketbeat.comNorthern Trust Corp Boosts Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Grows Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 20, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Has $3.59 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 17, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Graham Capital Management L.P.May 16, 2025 | marketbeat.comBNP Paribas Financial Markets Purchases New Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 15, 2025 | marketbeat.comGranahan Investment Management LLC Sells 314,396 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)May 13, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 40,700 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)May 13, 2025 | marketbeat.comCaptrust Financial Advisors Has $5.74 Million Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 11, 2025 | marketbeat.comLeerink Partnrs Issues Negative Forecast for CSTL EarningsMay 10, 2025 | marketbeat.comReal-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class ResultMay 9, 2025 | globenewswire.comAlgert Global LLC Increases Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 9, 2025 | marketbeat.comDimensional Fund Advisors LP Increases Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 9, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Price Target Lowered to $37.00 at Canaccord Genuity GroupMay 8, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Posts Earnings Results, Misses Expectations By $0.12 EPSMay 7, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call TranscriptMay 7, 2025 | msn.comCastle Biosciences Celebrates Skin Cancer Awareness MonthMay 7, 2025 | globenewswire.comTudor Investment Corp ET AL Boosts Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)May 7, 2025 | marketbeat.comCastle Biosciences, Inc.: Castle Biosciences to Acquire PreviseMay 6, 2025 | finanznachrichten.deBellevue Group AG Has $19.88 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)May 6, 2025 | marketbeat.comCastle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call TranscriptMay 5, 2025 | seekingalpha.com Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSTL Media Mentions By Week CSTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSTL News Sentiment▼1.761.01▲Average Medical News Sentiment CSTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSTL Articles This Week▼35▲CSTL Articles Average Week Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Veracyte News Addus HomeCare News PACS Group News Ardent Health News LifeStance Health Group News Progyny News GRAIL News National HealthCare News Teladoc Health News Viridian Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CSTL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts